Polen Capital Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,248
| Closed | -$784K | – | 122 |
|
|
2024
Q4 | $784K | Sell |
4,248
-1,256
| -23% | -$232K | ﹤0.01% | 113 |
|
|
2024
Q3 | $1.08M | Sell |
5,504
-211
| -4% | -$41.6K | ﹤0.01% | 101 |
|
|
2024
Q2 | $1.18M | Sell |
5,715
-345
| -6% | -$71.3K | ﹤0.01% | 97 |
|
|
2024
Q1 | $1.64M | Sell |
6,060
-268
| -4% | -$72.6K | ﹤0.01% | 92 |
|
|
2023
Q4 | $1.5M | Buy |
6,328
+1,323
| +26% | +$313K | ﹤0.01% | 101 |
|
|
2023
Q3 | $981K | Buy |
5,005
+50
| +1% | +$9.8K | ﹤0.01% | 94 |
|
|
2023
Q2 | $1.04M | Sell |
4,955
-514
| -9% | -$108K | ﹤0.01% | 92 |
|
|
2023
Q1 | $1.1M | Sell |
5,469
-219
| -4% | -$44.2K | ﹤0.01% | 89 |
|
|
2022
Q4 | $1.24M | Buy |
5,688
+1,038
| +22% | +$226K | ﹤0.01% | 85 |
|
|
2022
Q3 | $915K | Sell |
4,650
-35
| -0.7% | -$6.89K | ﹤0.01% | 81 |
|
|
2022
Q2 | $1M | Buy |
+4,685
| New | +$1M | ﹤0.01% | 80 |
|